PROCEPT BioRobotics CorporationPRCTNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-103.62M
↓ 30% below average
Average (5y)
$-79.63M
Historical baseline
Range
High:$-48.58M
Low:$-133.21M
CAGR
+15.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-103.62M | +22.2% |
| 2023 | $-133.21M | -60.4% |
| 2022 | $-83.03M | -43.3% |
| 2021 | $-57.93M | -19.2% |
| 2020 | $-48.58M | +5.5% |
| 2019 | $-51.43M | - |